🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessHas anyone dealt with mounjaro savings card? Page 2

Has anyone dealt with mounjaro savings card?

lucas_SP_BR Mon, Apr 13, 2026 at 12:26 PM 8 replies 596 viewsPage 2 of 2
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Apr 14, 2026 at 11:19 PM#6
My A1C is 5.4, which is normal, not prediabetes. So that avenue doesn't work for me. I've looked into it thoroughly. My fasting glucose is 92, fasting insulin is 8. Metabolically I'm annoyingly healthy for someone with a BMI of 38. All my health issues are mechanical — joint pain, sleep apnea, back problems. But insurance doesn't care about those for GLP-1 coverage.
Last edited: Apr 15, 2026 at 4:19 AM
18 13tane_welly, Dr.PathRoch, mona_PHX and 15 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Apr 15, 2026 at 1:15 PM#7
I'm also on FEHB (federal employee plan). Important update for 2026: Several FEHB plans added Zepbound coverage for the new plan year. Check: - GEHA Elevate Plus — added Zepbound, tier 4, $150 copay - MHBP Standard — added Zepbound with PA, 30% coinsurance - Kaiser Mid-Atlantic — covers Zepbound, $100 copay FEHB open season is November 10 - December 8. You can switch plans. It might be worth doing the math on premium difference vs. Zepbound coverage.
Last edited: Apr 15, 2026 at 4:15 PM
17 12laura_annarbor, JenMemphis, pat_auckland and 14 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Apr 16, 2026 at 3:11 AM#8
Thank you for this. I'm going to look at GEHA Elevate Plus. If the premium increase is less than $1,059/month (current cash price), switching plans is a no-brainer. Even at $150 copay plus whatever premium increase, it should be dramatically cheaper.
16 11mona_PHX, andrew_nyc, Dr.EndoEP and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Apr 16, 2026 at 5:06 PM#9
The Zepbound vs Mounjaro coverage disparity is a huge policy issue right now. The CBO estimated that if Medicare covered anti-obesity medications (currently excluded by statute), it would cost $35 billion over 10 years. That's why private insurers are also hesitant — the cost exposure is enormous. The Treat and Reduce Obesity Act has been reintroduced in Congress and would require Medicare Part D to cover FDA-approved anti-obesity drugs. If that passes, private insurers will likely follow within 2-3 years. But right now, weight management drugs are one of the last categories where insurers can legally just say no.
15 10Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 12 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Apr 19, 2026 at 11:54 AM#10
I gave up fighting insurance entirely. I use Zepbound through Lilly's direct program at $550/month (they dropped the price for self-pay in late 2025). Is it ideal? No. But I was spending more time and mental energy fighting my insurance than I was spending on the medication itself. Sometimes the path of least resistance is worth the premium.
39 12Dr.EndoIndy, tom_AK, josh_phd_bmore and 36 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register